Catalyst Wire Dossier Catalyst Wire Dossier

GPRC5D CAR-T cell therapy

GPRC5D-targeted CAR-T cell therapy
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GPRC5D CAR-T cell therapy, covering 2026-01-26 to 2026-01-26. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of GPRC5D CAR-T Cell Therapy in Relapsed/Refractory Plasma Cell Disorders [EARLY_Phase 1]

See pricing